Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023

SELL
$0.21 - $1.24 $9,202 - $54,336
-43,820 Reduced 59.22%
30,170 $7,000
Q4 2022

Feb 14, 2023

BUY
$0.99 - $2.91 $53,015 - $155,833
53,551 Added 262.0%
73,990 $87,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $2.27 $2,657 - $46,396
20,439 New
20,439 $42,000
Q1 2022

May 16, 2022

BUY
$3.67 - $7.63 $282,112 - $586,518
76,870 New
76,870 $388,000

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.